JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 7, 2008; DOI: 10.1124/jpet.108.139543


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.139543v1
326/2/363    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Waalkes, M. P
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Waalkes, M. P


Received for publication April 9, 2008.
Revised May 5, 2008.
Accepted for publication May 6, 2008.

Mineral Aresenicals in Traditional Medicines: Orpiment, Realgar, and Arsenolite

Jie Liu 1*, Yuanfu Lu 2, Qin Wu 2, Robert A Goyer 3, Michael P Waalkes 3

1 NCI at NIEHS 2 Zunyi Medical College 3 National Cancer Institute

* Address correspondence to: E-mail: liu6{at}niehs.nih.gov

Abstract

Mineral arsenicals have long been used in traditional medicines for various diseases, yet arsenic can be highly toxic and carcinogenic. Arsenic in traditional medicines typically comes from deliberate addition for therapeutic purposes, mainly in the form of mineral arsenicals including orpiment (As2S3), realgar (As4S4), and arsenolite (contains arsenic trioxide, As2O3). Inorganic arsenic is now accepted in Western medicine as a first line chemotherapeutic agent against certain hematopoietic cancers. This minireview analyzes the pharmacology and toxicology of these arsenicals used in traditional medicines. Orpiment and realgar are less soluble and poorly absorbed from the gastrointestinal tract, while the bioavailability of arsenic trioxide is similar to inorganic arsenic salts like sodium arsenite. Pharmacological studies show that arsenic trioxide and realgar are effective against certain malignancies. Orpiment and realgar are used externally for various skin diseases. Realgar is frequently included as an ingredient in oral traditional remedies for its antipyretic, antiinflammatory, antiulcer, anticonvulsive and anti-schistosmiasis actions, but the pharmacological basis for this inclusion still remains to be fully justified. Toxicological studies show that cardiovascular toxicity is the major concern for arsenic trioxide, and the gastrointestinal and dermal adverse effects may occur after prolonged use of mineral arsenicals. Little is known about possible secondary cancers resulting from the long-term use of any of these arsenicals. Similar to the safety evaluation of seafood arsenicals, total arsenic content alone appears to be insufficient for mineral arsenical safety evaluation. Arsenic speciation, bioavailability, and toxicity/benefit should be considered in evaluation of mineral arsenical-containing traditional medicines.


Key words: arsenic, arsenolite, cancer chemotherapy, oripiment, realgar, traditional medicines





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.